AH Equity Partners Bio I, L.L.C.

Insider Reports History

Entity
Company
Location
2865 Sand Hill Road, Suite 101, Menlo Park, CA
Signature
AH Bio Fund I, L.P. for itself and as nominee for AH Bio Fund I-B, L.P., By: AH Equity Partners Bio I, L.L.C., its General Partner, By: /s/ Scott Kupor, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by AH Equity Partners Bio I, L.L.C.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Camp4 Therapeutics Corp 10%+ Owner Common Stock 1.58M Oct 15, 2024 By AH Bio Fund I, L.P., as nominee
Camp4 Therapeutics Corp 10%+ Owner Common Stock 545K Oct 15, 2024 By AH Bio Fund IV, L.P., as nominee
Camp4 Therapeutics Corp 10%+ Owner Series A Prime Preferred Stock 0 Oct 15, 2024 By AH Bio Fund I, L.P., as nominee
Camp4 Therapeutics Corp 10%+ Owner Series B Preferred Stock 0 Oct 15, 2024 By AH Bio Fund I, L.P., as nominee

Insider Reports Filed by AH Equity Partners Bio I, L.L.C.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CAMP Camp4 Therapeutics Corp Oct 15, 2024 5 $8M 4 Oct 17, 2024 10%+ Owner
CAMP Camp4 Therapeutics Corp Oct 10, 2024 0 $0 3 Oct 10, 2024 10%+ Owner